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Abstract 
Oligomerization of protein into amyloid ﬁbrils is central to the pathogenesis of several 
neurodegenerative disorders. Amyloid ﬁbrillation and the cytotoxic actions of amyloids are 
membrane-associated processes. The interactions of amyloid-forming proteins with lipids at 
the membrane surface accelerate ﬁbrillation and induce membrane permeabilization. 
Oligomerization also plays a functional role in antimicrobial defense and controls the catalytic 
activity of phospholipase A2 (PLA2). The protein oligomerization and amyloid formation can 
be modulated by heat shock protein 70 (Hsp70). Thus, the aim of the present work was to study 
membrane-associated protein oligomerization and its modulation by Hsp70 on the 
phospholipid model membrane system. Sequence analyses revealed that antimicrobial 
peptides (AMPs) contained sequence motifs that showed propensities for self-assembly, 
aggregation, and oligomerization into amyloid ﬁbrils. The presence of such oligomerization-
mediating sequences was characteristic of amyloidogenic cytotoxic proteins, including gelsolin 
involved in familial Finnish type amyloidosis (FAF). 1-Palmitoyl-2-(9'-oxo-nonanoyl)-sn-
glycero-3-phosphocholine (PoxnoPC), an oxidized phospholipid, accelerated ﬁbrillation of the 
core amyloidogenic segment of gelsolin.The PoxnoPC-mediated ﬁbrillation of gelsolin was 
dependent on both the concentration and the aggregation state of PoxnoPC. Fibril growth 
followed simple nucleation-dependent kinetics with the formation of transient preﬁbrillar 
oligomers in the lag phase. 
         Subsequently, in order to understand the functional role of membrane-associated Hsp70, 
we studied lipid-Hsp70 interactions. The association of Hsp70 with phospholipid membranes 
was highly dependent on their lipid compositions. Hsp70 associated with phosphatidylcholine 
bilayers and penetrated into the hydrocarbon region. In contrast to the above data, in the 
presence of negatively charged phospholipids, Hsp70 bound peripherally to membrane 
surfacesby extended phospholipid anchorage. A speciﬁc pH-dependent association of Hsp70 
with bis(monoacylglycero)phosphate, an acidic phospholipid enriched in the inner lysosomal 
membrane, activated lysosomal acid sphingomyelinase and promoted cell survival. We also 
showed that the Hsp70 sustained the hydrolytic activity of PLA2 by modulating the 
oligomerization and transformation of PLA2 into amyloid ﬁbers. Hsp70 attenuated the 
lysophosphatidylcholine-induced inhibition and amyloid formation of PLA2 in an ATP-
dependent manner. Finally, an oligomerization-mediating sequence in PLA2 was identiﬁed. 
Synthetic peptides corresponding to amyloidogenic, aggregation-promoting regions inhibited 
the hydrolytic activity of PLA2. 
Keywords amyloid, antimicrobial peptides, ﬂuorescence, gelsolin, heat shock protein 70, 
membranes, oligomers, phospholipid, phospholipase A2, and tryptophan 
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1. REVIEW OF THE LITERATURE 
 
1.1. Overview of the cell membrane and phospholipids 
 
 
Biological membranes are essential components of cells, comprising thousands of 
distinct lipids (glycerophospholipids, sphingolipids, and sterols), sugars, and 
proteins (Kinnunen 1991, Sud et al. 2007). Membranes not only function as 
selective permeable barriers, but also divide cells into distinct structural and 
functional compartments, such as mitochondria, lysosomes, the Golgi apparatus, 
and the endoplasmic reticulum (ER, Mouritsen 2005). Cell membranes play 
important roles in a large number of vital physiological functions, such as cell-cell 
communication, cell division, cell signaling, cellular fusion, intra- and extracellular 
transport, and cell motility (Mouritsen 2005). Lipid-protein interactions in the 
membrane are key to understanding a large number of cellular processes including 
signal transduction, enzyme catalysis, and antimicrobial defense (Escriba et al. 
2008). Lipid-protein interactions are controlled by membrane-associated 
physicochemical properties, such as phase, curvature strain, lateral pressure, 
surface charge, and structure and composition of membrane lipids (Kinnunen et al. 
1994).  
The most widely accepted structure model for the cell membrane was proposed 
by Singer and Nicholson in 1972. They postulated that the membrane acts as a 
pseudo two-dimensional fluid, allowing both proteins and lipids to move freely 
(Singer et al. 1972). Since then, the development of new experimental techniques 
has contributed significantly to the advancement of our understanding of 
membrane structure and function. The lipid compositions of the plasma membrane 
and cell organelle membranes differ widely, and vary according to cell type. 
Eukaryotic cell membranes are heterogeneous and asymmetrical with respect to the 
composition, distribution, and physical state of lipids (Stier et al. 1973, Karnovsky 
et al. 1982, Kinnunen 1991). The exofacial leaflets of the plasma membrane are 
highly enriched in phosphatidylcholines (PCs) and sphingomyelins (SMs), whereas 
charged phosphatidylethanolamine (PE), phosphatidylserine (PS), 
phosphatidylinositol (PI), phosphotidylglycerol (PG), and phosphatidic acid (PA) 
are mainly found in the cytoplasmic leaflet (van Meer et al. 2008). Loss of lipid 
asymmetry has been observed in the plasma membrane of cancer cells. Moreover, 
anionic phospholipids, such as PS and PE, translocate to the outer surface of 
apoptotic cells (Zwaal et al. 2005). Sphingolipids and sterols are abundant in the 
plasma membrane, but only found in low amounts in the membranes of 
intracellular organelles (Zambrano et al. 1975, Spector et al. 1985). Bis-
Review of litrature 
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monoacylglycerophosphate (BMP) is a major constituent of late endosomes and 
lysosomes, whereas cardiolipin (CL) is largely confined to mitochondria (Comte et 
al. 1976, Kobayashi et al. 2002).  
In an aqueous environment, phospholipids spontaneously self-assemble into 
different shapes, such as micelles, vesicles, or bilayers (Israelachvili et al. 1980, 
Chan et al. 2007). The shapes of membrane structures depend on the effective 
molecular shape of the lipid described by packing parameter P = V/al (Israelachvili 
et al. 1980), where V represents the effective volume of the hydrophobic part of the 
molecule, a stands for the area of the hydrophilic head group, and l is the length of 
the chain(s) in their fully extended configuration. The single-chain phospholipids 
lyso-SM and -PC have p-values between 0.33 and 0.5 and therefore form micelles, 
whereas PC, PS, PI, PG, and PA have p-values close to 1 and therefore form stable 
lamellar bilayers. The effective molecular shape of the lipid is also influenced by 
hydrophobicity, hydrogen bonding, hydration, and electrostatic and van der Waals 
interactions. 
Lamellar lipid bilayers are the biologically most relevant lipid structure and may 
have different phase transitions depending upon the temperature and its lipid 
composition. The lipid bilayer shows a crystalline-like state (Lβ) at lower 
temperatures and a disordered, fluid-like state (Lα) at higher temperatures, 
particularly after transition temperatures (Tm, Kinnunen 1991, Alakoskela et al. 
2004). A phase transition is driven by the entropy gain arising from trans-gauche 
bond rotation of the acyl chains, which greatly increases the rate and extent of 
molecular motions (Heimburg 1998). A high degree of conformational flexibility 
exists in the Lα state, which leads to a decrease in bilayer thickness and van der 
Waals attractions between the hydrocarbon chains (Heimburg 1998). Cholesterol 
has been found to induce the liquid ordered phase to a phospholipid bilayer by 
attenuating the rotational and lateral diffusion of the phospholipid in bilayers and is 
very efficient in attenuating membrane partitioning and intercalation of 
amphipathic peptides (Sood et al. 2008a, Sood et al. 2008b). 
The membrane surface charge and potential have been shown to regulate binding 
of peripheral proteins to membrane surface (Rytomaa et al. 1992, Kinnunen et al. 
1994). The presence of anionic lipids, such as PS, CL, BMP, and PA, in the 
membrane attracts positively charged ions at the membrane surface (Cevc 1990). 
The anionic membrane surfaces also attract protons, creating a low pH 
environment with the bulk remaining unaltered in a buffer medium. Membranes 
containing 20% CL cause a high local negative surface charge, which attracts 
protons, thereby generating a local low pH environment on the membrane surface 
(Gorbenko et al. 2006b).  
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1.2. Membrane-associated amyloid formation 
 
 
Protein oligomerization into amyloid fibrils has been implicated in the 
pathogenesis of several debilitating neurodegenerative diseases (Dobson 1999) and 
has been shown to lead to progressive accumulation of protein in amyloid plaques 
or inclusion bodies (Dobson 2003, Chiti et al. 2006). Many studies using animal 
models and biochemical and biophysical experiments support that aggregation and 
amyloid formation by beta amyloid peptide (Aβ), gelsolin, α-synuclein (α-syn), and 
islet amyloid polypeptide (IAPP), respectively, lead to development of Alzheimer’s 
diseases (AD), Finnish type familial amyloidosis (FAF), Parkinson’s diseases (PD), 
prion disease, and type 2 diabetes (Dobson 2003, Kinnunen 2009, Kinnunen et al. 
2012). In each of the above diseases, specific proteins self-assemble into a variety 
of small, soluble oligomers that undergo further assembly into protofibrils before 
finally becoming mature fibrils (Dobson 2003). The amyloid fibers consist of 
highly ordered cross β-sheet structures that align perpendicularly to the fibril long 
axis (Sunde et al. 1997). Transient prefibrillar oligomers or protofibrils are 
cytotoxic species, whereas mature fibrils have been shown to be stable and 
nontoxic to the cell (Bucciantini et al. 2002, Stefani et al. 2003). The 
permeabilization of the cell membrane by intermediate protofibrils renders 
biological membranes leaky, which causes cell death (Kayed et al. 2004, Stefani 
2007, Hebda et al. 2009). Increasing evidence indicates that interactions between 
amyloid fibrils and cell membranes may essentially contribute to amyloid 
cytotoxicity. 
Phospholipid membranes are important in controlling amyloid formation 
(Gorbenko et al. 2006a, Kinnunen 2009). Membrane surfaces promote protein 
accumulation and provide an environment that can induce conformational changes 
to destabilize the native structure of a protein. Membrane also serves as a template 
for protein assembly. It also alleviates electrostatic repulsion between charged 
monomers and eventually drives an ordered polymerization of cytotoxic 
proteins/peptides (Kinnunen 2009). Several experimental data have shown that the 
presence of acidic phospholipids in the lipid membrane accelerates amyloid 
formation by amyloid forming peptides (Zhao et al. 2004). 
 
 
1.2.1. Amyloid formation by antimicrobial peptides (AMPs) 
 
AMPs are ubiquitously found in many species and are one type of evolutionary 
effector molecule involved in the mechanisms of host defense (Lehrer et al. 1999, 
Review of litrature 
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Hancock et al. 2000). AMPs play essential roles in eukaryotic innate immunity and 
provide the first line of defense against microbial invasion (Tossi et al. 2000, 
Zasloff 2002a, Zasloff 2002b). AMPs exhibit a broad spectrum of activity against 
gram-negative and gram-positive bacteria, fungi, and yeast, and some AMPs have 
anticancer and antiviral activities (Tiozzo et al. 1998). Interestingly, many AMPs 
are effective against drug-resistant pathogens (Koczulla et al. 2003). Therefore, 
understanding of the mechanisms of action of AMPs is required in order to develop 
a new class of peptide-based antibiotics for therapeutic purposes (Hancock 1997, 
Hoskin et al. 2008). 
The structural diversity of AMPs is vast. Based on their secondary structures, 
AMPs are classified into four major classes: α-helical, β-sheet, looped, and 
extended peptides (Hancock et al. 1998, Epand et al. 1999). The mechanism 
through which AMPs execute their cytotoxic functions depends on a number of 
physiochemical properties of their amino acid sequences, i.e., net positive charge, 
amphipathicity, hydrophobicity, and aggregation in a membrane environment (Shai 
1999). The negative charge of the outer surface of the bacterial membrane 
promotes the binding of cationic AMPs (Matsuzaki 1999). A large number of 
AMPs exert their antimicrobial and cytotoxic effects by disrupting the organization 
of their target cell membrane, causing membrane permeabilization (Kourie et al. 
2000). Membrane permeabilization has been explained in terms of different 
models, such as the carpet, barrel-stave, toroidal-pore, and detergent-type 
membrane lytic mechanisms (Shai 1999).  
Table 1 
 
In the presence of acidic phospholipid bilayers, several AMPs (Table 1) form 
Congo red- and thioflavin T (ThT)-stained fibrils, a characteristic feature of 
amyloid-type fibers (Zhao et al. 2004, Zhao et al. 2005). Amyloid-forming 
Membrane-induced amyloid formation by host defense peptides 
AMP Ref. 
LL37 Sood et al. 2008a 
Magainin 2 Zhao et al. 2004 
Melittin Zhao et al. 2004 
Plantracin A Zhao et al. 2006 
Temporin (tem) B and L Sood et al. 2007 
Sakacin P Zhao et al. 2004 
Eosinophil cationic peptide Torrent et al. 2010 
Dermaseptins  Auvynet et al. 2008, Gossler-Schofberger et al. 
2009 
Protegrin-1 Jang et al. 2011 
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peptides/proteins constitute another class of cytotoxic biomolecules. They exert 
their action by permeabilization of cellular membranes in a manner similar to that 
of AMPs (Kourie et al. 2000). The cytotoxic action of amyloid-forming proteins 
seems to be generic and occurs via transient prefibrillar oligomers in the 
folding/aggregation free-energy landscape preceding the formation of nontoxic 
mature amyloid (Dobson 2003, Kayed et al. 2004). AMP-lipid interactions at the 
membrane surface increase the rate of peptide aggregation and fibrillogenesis, 
especially when the membrane contains anionic phospholipids (Gorbenko et al. 
2006a).  
The “leaky slit” model was proposed based on amyloid formation by AMPs on 
the membrane surface (Fig. 1, Zhao et al. 2006). According to the leaky slit model, 
membrane-bound AMPs are arranged in a linear, amphipathic array to form 
oligomers or protofibirils, which drive the membrane to become leaky (Zhao et al. 
2006). The hydrophobic surface of the above oligomers interacts with the 
hydrophobic core and hydrophilic surface of the membrane, which line up in a 
channel to form the so-called “leaky slit” (Zhao et al. 2006). The amphipathic and 
fibrillar nature of oligomers is essential for permeabilization and cytotoxicity in 
this model. For several AMPs, α-helix formation is augmented in the presence of 
phospholipids (Turner et al. 1998, Zhao et al. 2002, Sood et al. 2007). The 
amphipathic characteristics of AMPs are enhanced in response to this α-helix 
transition, with hydrophilic and hydrophobic side chains becoming accommodated 
on different faces of the helix (Epand et al. 1999, Shai 1999). The hydrophobic 
face of the helix inserts into the membrane and contacts the acyl chain region of the 
bilayer. Simultaneously, the cationic hydrophilic face of the amphipathic α-helix 
interacts electrostatically with the head groups of negatively charged 
phospholipids. This electrostatic interaction between AMPs and anionic head 
groups neutralizes the excess charge of membrane-associated AMPs and reduces 
the repulsion between them (Abraham et al. 2007). Membranes thus provide an 
environment where AMPs can adopt conformations and orientations that promote 
their aggregation.  
 
Figure 1: The “leaky slit” membrane defect caused by transient amphipathic α-helical oligomers. The 
hydrophobic surface of the oligomers is in contact with the hydrocarbon chain of the bilayer, while 
the hydrophilic surface interacts with hydrophilic head groups of the lipids. (Reprinted with 
permission from, Zhao et al. 2006). 
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The described characteristic amyloid-type fiber formation by AMPs 
indicates that sequences of AMPs should contain motifs responsible for 
conformational changes and oligomerization on the membrane surface. These 
features are expected to be represented by relatively short stretches and could be 
identified by sequence analyses.  
 
 
1.2.2. Amyloid formation by gelsolin in Finnish type familial amyloidosis (FAF)  
 
 
FAF is a globally distributed neurodegenerative disease, originally reported in 
southeastern Finland (de la Chapelle et al. 1992). FAF is typically an age-related 
disorder that manifests in the third or fourth decade of life. An extensive deposition 
of D187N mutant gelsolin fragments have been observed as an amyloid in various 
tissues of patients suffering from FAF (Maury et al. 1990, Maury 1991, Maury et 
al. 1992, Kiuru et al. 1999, Kiuru-Enari et al. 2005, Tanskanen et al. 2007, 
Shokouhi et al. 2008). Gelsolin, a multifunctional hexameric protein made up of 
homologous domains, functions to regulate actin assembly (Janmey et al. 1987, 
Yin 1987). Initially, mutation of Asp-187 to Asn was thought to render gelsolin 
susceptible to aberrant proteolysis, generating an amyloidogenic precursor that 
deposit as amyloid plaque in FAF (Chen et al. 2001, Huff et al. 2003, De Strooper 
2010). Mechanisms of amyloid formation by gelsolin have been studied by several 
laboratories over the past few decades (Kelly 1996, Ratnaswamy et al. 1999, 
Sekijima et al. 2005, Suk et al. 2006). However, the molecular mechanism through 
which gelsolin aggregation leads to neurodegeneration in FAF remains unknown. 
Interestingly, the two forms of gelsolin (intracellular 81 kDa and secreted 83 kDa) 
are generated by alternative splicing. While both splice variants may contain the 
D187N/Y mutation, only the secreted 83-kDa gelsolin is associated with 
amyloidosis in FAF (Kangas et al. 2002). The accumulation of amyloid-like 
aggregates in the extracellular matrix strongly suggests that changes in the local 
chemical environment of the membrane with age play an important role in FAF 
(Kinnunen 2009, Kinnunen et al. 2012). 
Oxidative stress has been implicated in the pathogenesis of a number of age-
related diseases, including FAF (Montine et al. 2002, Tanskanen et al. 2006, Li et 
al. 2010, Singh et al. 2010). Depletion of intracellular antioxidant pools together 
with the inability to overcome oxidative damage by enzymes such as superoxide 
dismutases, catalases, and glutathione peroxidase drastically increases reactive 
oxygen species (ROS) levels in the cell (Halliwell 1989, Galli et al. 2005, Bieschke 
et al. 2006). ROS introduce a plethora of chemical modifications in biomolecules, 
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especially to membrane phospholipids (Fruhwirth et al. 2007, Stemmer et al. 
2012). Recent studies have demonstrated that oxidatively modified lipids can 
accelerate the formation of amyloid fibrils by Aβ and IAPP (Koppaka et al. 2000, 
Komatsu et al. 2007, Kinnunen et al. 2010). Oxidatively modified phospholipids 
also represent molecular targets for amyloidogenic peptides, such as LL-37 
(Mattila et al. 2008). Accordingly, investigation of gelsolin fibrillation in the 
presence of the oxidized phospholipids will serve as a foundation for understanding 
the aggregation of gelsolin in age related FAF. 
 
 
1.2.3. Amyloid formation in the control of enzyme activity  
 
 
Amyloid formation is not only associated with host defense mechanisms and 
neurodegenerative disorders, but also plays an important role in controlling the 
activity of lipid-associated enzymes, such as phospholipase A2 (PLA2). This 
enzyme constitutes one of the largest families of lipolytic enzymes, which catalyze 
the hydrolysis of the ester bond at the sn-2 position of glycerolphospholipids, 
releasing free fatty acids and lysophospholipids (Balsinde et al. 1999, Balsinde et 
al. 2002). PLA2 plays an important functional role in metabolism, digestion, 
antimicrobial activity, and cellular signaling (Six et al. 2000). The PLA2 
superfamily currently consists of 15 groups of proteins, which differ in their 
primary sequences, structures, and catalytic mechanisms (Scott et al. 1990, Dennis 
1997, Six et al. 2000). The catalytic mechanisms and structures are conserved with 
a high degree of sequence homology among secretory PLA2 (sPLA2) from 
different species and groups (Dennis 1994, Six et al. 2000). PLA2 has been 
implicated in diverse inflammatory diseases, such as cancer, ischemia, 
atherosclerosis, and schizophrenia (Gattaz et al. 1987, Farooqui et al. 2006). 
Moreover, PLA2 is major protein component of venom. 
The activity of PLA2 is influenced by the composition and phase state of the 
phospholipid interface (Pieterson et al. 1974, Wells 1974, Op den Kamp et al. 
1975). Oligomerization of PLA2 into catalytically active prefibrillar oligomers is 
involved in the control of PLA2 hydrolytic activity (Code et al. 2008). The 
expression of hydrolytic activity of PLA2, accompanied by enhancement of ThT 
fluorescence has been observed, and followed by the formation of inactive Congo 
red-stained amyloid-like fibrils (Code et al. 2008). Moreover, incubation of PLA2 
with lysoPC in vitro induces fibrillation and results in PLA2 inhibition 
(Cunningham et al. 2008, Code et al. 2010). PLA2 also forms fibrils on supported 
lipid bilayers, as demonstrated by atomic force and fluorescence microscopy 
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(Chibowski et al. 2008, Chiu et al. 2009). Amyloidogenic peptides, such as Aβ, as 
well as several host defense peptides, such as indolicidin, tem B, tem L, and 
magainin, activate PLA2 (Lehtonen et al. 1995, Zhao et al. 2003). Hetero-
oligomeric interactions and fibril formation between PLA2 and tem B have also 
been observed (Code et al. 2009).  
 
1.3. Modulation of amyloid formation by heat shock protein 70 
(Hsp70) 
 
 
1.3.1. Structure and function of Hsp70  
 
Hsp70 constitutes a highly conserved family of protein chaperones that regulate 
protein homeostasis and promote cell survival under physiological conditions 
(Hartl et al. 1995). The E. coli Hsp70 protein DnaK shares approximately 50% 
amino acid identity with eukaryotic Hsp70 proteins (Suppini et al. 2004). 
Interestingly, all eukaryotes have more than one gene encoding Hsp70 proteins. 
The human Hsp70 family consists of at least 13 members, which have been 
characterized according to their different expression levels, amino acid sequences, 
subcellular localizations, and functions (Daugaard et al. 2007, Brocchieri et al. 
2008, Kampinga et al. 2009). Some Hsp70 proteins are constitutively expressed, 
whereas others are strictly stress-inducible (Daugaard et al. 2007). The four major 
members of the human Hsp70 family are stress-inducible Hsp70 (Hsp70-1a and 
Hsp70-1b, 72 kDa), constitutively expressed Hsc70 (Hsp70-8, 73 kDa), glucose-
regulated protein 78 (Hsp70-5 or Grp78, 78 kDa; localized in the endoplasmic 
reticulum), and mtHsp70 (Hsp70-9, mortalin, or Grp75, 75 kDa; localized in the 
mitochondria) (Munro et al. 1986, Dworniczak et al. 1987, Bhattacharyya et al. 
1995). 
The structure of Hsp70 proteins is highly conserved across species and consists 
of two domains, the N-terminal nucleotide-binding domain (NBD, 44 kDa, 
residues 1–385) and the C-terminal substrate-binding domain (SBD, 28 kDa, 
residues 386–640), as shown in Fig. 2 (Bukau et al. 1998). Several residues of the 
NBD are involved in ATP binding, but K71 is essential for the hydrolysis of ATP 
(Flaherty et al. 1994, Wilbanks et al. 1994, O'Brien et al. 1996). Three distinct 
conformations of the NBD have been demonstrated: nucleotide-free, ADP-bound, 
and ATP-bound NBD (Zhang et al. 2004). SBD is subdivided into the substrate-
binding β-sheet subdomain (SBDβ, 25 kDa, residues 393–502), composed of eight 
antiparallel β-strands, and an α-helical subdomain (SBDα, 10 kDa), having five α
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helices that function as a lid (Zhu et al. 1996). The C-terminal EEVD motif of SBD 
is conserved in all eukaryotic Hsp70 proteins and facilitates the binding of co-
chaperones (Schlecht et al. 2011). 
 
Figure 2: Tentative 3D ribbon structure of Hsp70 based on the crystal structures of bovine Hsc70 and 
the SBD of Hsp70 (pdb codes: 1yuwA and 2p32), homology modeled by the Discovery studio. Hsp70 
has two functional domains NBD and SBD, which are shown in blue and green, respectively. W90 
and W580 are shown as ball and stick models (red). 
 
NBD and SBD are connected via a flexible and highly conserved 14-residue 
linker (Mosser et al. 2000). The conformations of NBD and SBD are coupled for 
Hsp70 (Fung et al. 1996), DnaK (Buchberger et al. 1995), and Grp78 (Kassenbrock 
et al. 1989). NBD appears to regulate the conformation of SBD in an ATP-
dependent manner, enabling SBD to recognize and interact with extended 
hydrophobic regions in partially unfolded proteins (Rudiger et al. 1997a, Rudiger 
et al. 1997b). Interdomain communication upon ATP binding is relayed by the 
conformational switching of the proline from cis to trans (i.e., the proline switch) 
in NBD, thereby constituting a molecular switch to control opening and closing of 
the SBD (Bertelsen et al. 2009, Chiappori et al. 2012). The presence of ATP in 
NBD accelerates the binding and release of polypeptides in SBD. However, it is 
still unclear whether the binding or hydrolysis of ATP causes the release of 
peptides (Hu et al. 2006). 
Hsp70 facilitates a range of processes, including protein folding, transport of 
proteins across membranes, and regulation of protein degradation and aggregation 
(Lindquist, et al. 1988). In addition to counteracting protein aggregation, Hsp70 
also promotes cell survival by inhibiting the permeabilization of lysosomal 
membranes (Nylandsted, et al. 2004). 
 
 
1.3.2. Protective role of Hsp70 in protein misfolding disorders  
 
 
Cells have evolved complex cellular machinery, including molecular chaperones, 
which promote efficient folding and prevent aggregation (Tyedmers et al. 2010, 
W90 
W580 
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Hartl et al. 2011). Several studies have shown that Hsp70 plays a crucial role in 
modulating protein aggregation and neurodegeneration (Muchowski et al. 2005). 
Hsp70, along with many chaperones, provides the first line of defense against 
aberrant misfolded and aggregated proteins in the crowded cellular environment 
(Ellis 2001, Muchowski et al. 2005). Interestingly, overexpression of Hsp70 
inhibits the formation of toxic oligomers and prevents the formation of amyloid 
aggregates in different diseases models (Sittler et al. 2001, Auluck et al. 2002, Lotz 
et al. 2010). The key function of Hsp70 is to help proteins fold correctly into their 
functional conformation and to prevent nonspecific aggregation of misfolded 
proteins (Lindquist et al. 1988).  
Hsp70 accumulation has been observed in amyloid plaques of patient suffering 
from Alzheimer’s disease (AD) (Hamos et al. 1991, Perez et al. 1991). 
Pathologically, AD is characterized by an extracellular accumulation of Aβ in the 
senile plaque and the intracellular accumulation of abnormally phosphorylated tau 
protein as neurofibrillary tangles (Hardy et al. 2002). Hsp70 transiently interacts 
with amyloid precursor protein in the ER and attenuates the secretion of Aβ 
peptides (Yang et al. 1998). Further studies in a Caenorhabditis elegans disease 
model of AD have shown that Hsp70 interacts with intracellular Aβ in the cytosol 
(Fonte et al. 2002). In vitro studies have indicated that Hsp70 inhibits early stages 
of aggregation, but does not prevent fibrillation (Evans et al. 2006). Hsp70 also 
activates microglia for phagocytic digestion of extracellular Aβ plaques (Kakimura 
et al. 2002). Overall, Hsp70 overexpression plays a neuroprotective role and 
rescues neurons from the toxic effects of Aβ (Kakimura et al. 2002, Magrane et al. 
2004).  
A similar neuroprotective role of Hsp70 has also been observed in Parkinson’s 
disease (PD), a movement disorder caused by progressive and selective loss of 
dopaminergic neurons (Lotharius et al. 2002, Witt 2010).  In PD α-syn aggregates 
and accumulated in inclusion bodies. Hsp70 associates with prefibrillar species to 
prevent fibril assembly of α-syn and attenuate the cytotoxicity induced by soluble 
oligomers (Hohfeld et al. 1995, Dedmon et al. 2005, Huang et al. 2006, Pemberton 
et al. 2011). The SBD of Hsp70 interacts with α-syn via its central hydrophobic 
region (residues 61–95), a hydrophobic β-sheet core involved in initiating the 
conversion of α-syn into amyloid fibrils (Giasson et al. 2001, Luk et al. 2008). This 
finding is consistent with in vivo observations that Hsp70 overexpression reduces 
α-syn accumulation and toxicity in both mouse and Drosophila models of PD 
(Auluck et al. 2002, Klucken et al. 2004). 
Moreover, recent results have indicated that surface of phospholipid membranes 
accelerate protein aggregation and oligomerization leading to formation of 
cytotoxic intermediates. Accordingly, elucidation of the molecular mechanisms of 
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Hsp70 membrane attachment is required in order to understand role of Hsp70 in 
membrane-induced protein oligomerization. 
 
 
1.3.3. Membrane association of Hsp70 
 
 
Homologous members of the Hsp70 family are present in all cellular 
compartments, including the cytosol, nucleus, mitochondria (Bhattacharyya et al. 
1995), lysosomes (Nylandsted et al. 2004), endosomes (Kang et al. 2007), ER 
(Lammert et al. 1997), and plasma membranes (Multhoff et al. 1995, Hantschel et 
al. 2000, Farkas et al. 2003). In primary tumors of different origins, a fraction of 
stress-induced Hsp70 translocates to the outer surface of the plasma membrane and 
the membranes of the endolysosomal compartment (Hantschel et al. 2000, 
Nylandsted et al. 2004). Hsp70 is expressed at elevated levels in various human 
tumors, and the level of Hsp70 expression often correlates with tumor grade and 
poor prognosis in human breast cancer (Ciocca et al. 2005). Hsp70 also blocks 
apoptotic pathways in the mitochondria (Powers et al. 2009). Recently, the ER-
localized Hsp70 was found to promote the proliferation of tumor cells (Lee et al. 
2008). Hsp70 also inhibits lysosomal membrane permeabilization, which 
effectively inhibits tumor cell death by the release of lysosomal proteases into the 
cytosol (Nylandsted et al. 2004). Multiple reports have demonstrated the 
association of Hsp70 family members with lipid membranes in normal cells, tumor 
cells, and tumor-derived cell lines (Alder et al. 1990, Multhoff et al. 1995, 
Mamelak et al. 1997, Arispe et al. 2000, Gross et al. 2003). However, the 
mechanisms mediating Hsp70 association with the lipid membrane remain 
unknown. Accordingly, elucidation of the interactions of Hsp70 with organelle-
specific phospholipids is critical to improving our understanding of the functions of 
membrane-associated Hsp70.  
 
 
Aims of the study 
26 
 
2. AIMS OF THE STUDY 
The purpose of the present work was to study membrane-associated amyloid 
formation and its modulation by Hsp70.  
 
The major objectives of the study were 
1. To identify oligomerization-mediating sequences in α-helical AMPs 
2. To study the effects of oxidized phospholipids in gelsolin fibrillation  
3. To investigate phospholipid-Hsp70 interactions 
4. To investigate the influence of Hsp70 on PLA2 oligomerization 
5. To assess the hydrolytic activity of PLA2 in presence of its 
oligomerization-mediating sequences  
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3. MATERIALS AND METHODS 
Detailed descriptions of the materials and methods used in this study can be found 
in the published articles associated with this work (I–VI). Short descriptions are 
given here for easy reference (Table 2). 
 
3.1. Materials 
 
 
1-Palmitoyl-2-(9'-oxo-nonanoyl)-sn-glycero-3-phosphocholine (PoxnoPC), 1-
palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine (PazePC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-rac-glycerol (POPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-
serine (POPS), 1,1',2,2'-tetraoleoyl cardiolipin (toCL), BMP, and lysoPC (1-
hexadecanoly-2-lyso-sn-glycerol-3-phosphocholine) were from Avanti Polar 
Lipids (Alabaster, AL, USA). 1-Octosanyl-2-(pyren-1-yl) hexanoyl-sn-glycero-3-
phosphatidylmonomethyl ester (C28-O-PHPM) was from Invitrogen (Eugene, OR, 
USA). Acrylamide (AcrA), cholesterol, EDTA, Hepes, NaCl, ThT, and bee venom 
(bv) PLA2 were from Sigma (St. Louis, MO, USA), and sphingosine was from 
Matreya (Pleasant Gap, PA, USA). KMYFNLI, YNFLIMK, AALSYGFYG, wild 
type gelsolin179–194 (wtG179–194, SWESFNNGDCFILDLG), and the Finnish mutant 
type D187N gelsolin179–194 (FtG179–194, SWESFNNGNCFILDLG) were from 
Genscript Corporation (Piscataway, NJ, USA). Tears were collected from healthy 
volunteers after a brief exposure to the vapors from freshly minced onions. The 
collected lacrimal fluid (Lf) was stored at -20°C until use. wtHsp70, Hsp70-W90F, 
Hsp70-W580F, Hsp70-∆SBD, and Hsp70-∆NBD constructs were supplied by Prof. 
Marja Jäättelä (Copenhagen, Denmark). BMP, POPS, and toCL were brominated 
as described by East and Lee (East et al. 1982) to yield bis[mono(9,10)-
dibromostearoyl]glycerol-phosphate (Br4BMP), 1-palmitoyl-2-(9,10-dibromo)-
stearoyl-sn-glycero-3-phospho-L-serine (Br2PS), and tetra(9,10-
dibromostearoyl)cardiolipin (Br8CL). The purities of the lipids were verified by 
thin-layer chromatography on silicic acid-coated plates (Merck, Darmstadt, 
Germany) developed with a chloroform/methanol/water mixture (65:25:4, v/v/v). 
Examination of the plates after iodine staining revealed no impurities. Lipid stock 
solutions were prepared in chloroform and stored at -20°C. Concentrations of the 
lipid stock solutions were determined gravimetrically using a high-precision 
electrobalance (Cahn, Cerritos, CA, or SuperG, Kibron Inc., Espoo, Finland) as 
described previously (Tejera-Garcia et al. 2012), while pyrene-labeled lipids were 
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determined spectrophotometrically using the molar extinction coefficient ε = 
42,000 cm−1 at 342 nm.  
 
3.2. Methods 
 
 
Experiments were carried out in accordance with the methods discussed in the 
original publications. Detailed experimental procedures used in this thesis are 
given in the respective publications (I–VI).  
 
 
3.2.1. Sequence analysis using bioinformatics tools  
 
 
The sequences of 76 temporins from different species and 112 AMPs belonging to 
diverse families were retrieved from the literature and the Antimicrobial Peptide 
Database, respectively (Wang et al. 2004). Sequences of bv and human Lf PLA2 
were retrieved from NCBI. Sequences were analyzed by the CSSP (Boden et al. 
2006), SecStr (Hamodrakas 1988) online server for the identification of regions 
with conformational flexibility as well as for susceptibility to oligomerization, 
aggregation, and amyloid formation as predicted by AGGRESCAN (Conchillo-
Sole et al. 2007), TANGO (Fernandez-Escamilla et al. 2004), and PASTA (Trovato 
et al. 2007). 
 
 
3.2.2. Preparation of large unilamellar vesicles (LUV) and lipid dispersion 
 
 
Lipids were dissolved and mixed in chloroform to obtain the indicated 
compositions before removing the solvent under a stream of nitrogen. Lipid 
residues were subsequently maintained under reduced pressure for at least two 
hours and then hydrated for 60 min at a temperature above the Tm of the lipid 
(above the main phase transition temperature of the lipid) with the indicated buffers 
to yield the desired lipid concentration. In order to obtain LUV, the hydrated lipid 
mixtures were extruded through polycarbonate membranes with a 100-nm pore size 
(Nucleapore Inc., Pleasanton, CA, USA) using a LiposoFast small-volume 
homogenizer (Avestin, Ottawa, Canada). Liposomes around 100 nm size have 
prepared and utilized for various medical applications and drug delivery (Zou et al. 
2010, Tejera-Garcia et al. 2011, Buckiova et al. 2012, Ranjan et al. 2012). To 
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obtain aqueous dispersions of neat PoxnoPC and lysoPC, solutions were placed in 
a bath sonicator for 20 min instead of using an extruder, and samples were 
vortexed several times. Small unilamellar vesicles (SUVs) for PLA2 kinetic studies 
were prepared by rapidly injecting ethanolic lipid stock solution into the buffer 
with a Hamilton microsyringe. Details concerning the preparation of vesicles used 
in this study are given in the respective original publications (II–VI). 
 
3.2.3. Fluorescence spectroscopy  
 
 
3.2.3.1. Thioflavin T (ThT) kinetic assay 
 
 
The kinetics of fibril formation were monitored by fluorescence spectroscopy for 
50 μM ThT in a total volume of 200 μL of 20 mM Hepes, 0.1 mM EDTA, and 150 
mM NaCl (pH 7.0) using a fluorescence microplate reader (SPECTRAFluor Plus, 
Tecan GmbH, Salzburg, Austria), equipped with 430/35 excitation and 485/10 
emission filters. ThT fluorescence was monitored over time at 27°C, and the data 
from wells were corrected for baseline, normalized, and plotted as fluorescence 
intensity (a.u.) vs. time. Kinetic parameters (lag time, t1/2, and Kapp) were derived 
for each of these curves by fitting the data as described previously (Nielsen et al. 
2001). 
 
 
3.2.3.2. Steady-state Trp fluorescence measurements  
 
 
All fluorescence measurements were conducted with a Perkin-Elmer LS50B 
spectrofluorometer using quartz cuvettes with a 1-cm path length and both 
emission and excitation bandpasses set at 5 nm. Excitation was set at 290 or 295 
nm, and emission recorded from 308 to 450 nm, averaging three or five scans. 
Spectra were corrected for the contribution of light scattering in the presence of 
vesicles, normalized, and corrected for volume changes. From these data, the 
emission peak positions, peak intensities, and spectral centers of mass were 
determined. 
 
 
3.2.3.3. Quenching of Trp emission by acrylamide (AcrA) 
 
 
In order to determine the exposure of Trp to the aqueous phase, AcrA, a water-
soluble collisional quencher (Tallmadge et al. 1989), was added in six subsequent 
micromolar aliquots. Spectra were recorded as described above in the absence or 
presence of the indicated lipid compositions. All data were adjusted by subtracting 
Materials and methods  
30 
 
background measurements and light scattering due to liposomes, normalized, and 
corrected for volume changes and the inner filter effect.  
 
3.2.3.4. Quenching of Trp emission by brominated phospholipids 
 
 
Liposomes containing brominated phospholipids (6,7-, 9,10-, and 11,12-Br2PC, 
Br2PS, Br4BMP, or Br8CL) were used to monitor possible contacts of the Trp 
residues of Hsp70 with the lipid acyl chains (McIntosh et al. 1987). Differences in 
the quenching of Trp fluorescence by (6,7)-, (9,10)-, and (11,12)-Br2-PC were used 
to estimate the apparent depth of penetration of Trp into the lipid bilayers by the 
parallax method (Chattopadhyay et al. 1987).  
 
 
3.2.4. Penetration of Hsp70 into lipid monolayers 
 
 
Penetration of Hsp70 into lipid monolayers (Langmuir-films) residing on a 
gas/water interface was studied as described in Publication III. 
 
3.2.5. 90-degree light scattering 
 
 
Intensity of 90° light scattering was used to assay Hsp70 binding to LUV, as 
described by Nelsestuen and Lim (Nelsestuen et al. 1977).  
 
 
3.2.6. Transmission electron microscopy 
 
 
FtG179–194 fibrils in the presence and absence of PoxnoPC were assessed by FEI 
Tecnai F12 (Philips Electron Optics, Eindhoven, Netherland) electron microscope 
operated at 80 kV. 
 
 
3.2.7. Assay for phospholipase A2 (PLA2) 
 
 
PLA2 activity was determined by a kinetic assay as previously described (Thuren 
et al. 1985, Thuren et al. 1987, Thuren et al. 1988, Mustonen et al. 1998).  
 
Materials and methods  
31 
 
Table 2 
List of methods used in articles I–VI 
Experiment II III IV V VI 
ThT fluorescence assay X     
Steady-state Trp fluorescence measurements X X X   
Quenching of Trp emission by AcrA X X    
Quenching of Trp emission by brominated 
phospholipids 
 X    
Penetration of the Hsp70 into lipid monolayers  X    
90° light scattering   X   
Transmission electron microscopy X     
Assay for PLA2    X X 
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4. RESULTS 
 
4.1. Prediction of conformational ambiguity and amyloidogenic 
regions  
 
 
4.1.1. α-Helical AMPs (I) 
 
 
In order identify the structural motifs required for aggregation and amyloid 
formation, we analyzed sequences of a diverse group of α-helical AMPs (112 
peptides) and temporins (76 peptides), for a total of 188 peptides, by bioinformatics 
tools. CSSP (Boden et al. 2006) and SecStr (Hamodrakas 1988) identified 161 and 
152 AMPs, respectively, that contained motifs of varying length having intrinsic 
preferences for both α-helix and β-sheet structures and were potentially capable of 
undergoing conformational changes (Table 3).  
Aggregating and amyloidogenic regions in α-helical AMPs were searched by 
AGGRESCAN (Conchillo-Sole et al. 2007), PASTA (Trovato et al. 2007), and 
TANGO (Fernandez-Escamilla et al. 2004). Out of 188 AMPs, 175, 120, and 155 
were found to have regions containing amyloidogenic motifs potentially forming 
aggregates and amyloids, respectively, using these three servers (Table 3). 
Importantly, conformational switches predicted in the sequences of these AMPs 
(Young et al. 1999) coincided with the above high-packing density aggregating and 
amyloidogenic regions. In conclusion, these short amino acid stretches in the 
AMPs showed propensities for random coil, α-helix, and β-sheet structures, as well 
as for self-assembly, aggregation, and oligomerization into amyloid fibrils. 
Table 3 
Number of positive predictions by respective algorithms 
Method AMPs (122) Temporins (76) 
CSSP 103 58 
SecStr 82 70 
AGGRESCAN 107 68 
PASTA 82 38 
TANGO 95 60 
 
4.1.2. PLA2 (VI) 
 
 
The aggregation and fibrillation of PLA2 at the membrane interface suggests that 
PLA2 sequences possess structural features promoting oligomerization and 
aggregation. Accordingly, PLA2 sequences were analyzed by AGGRESCAN 
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(Conchillo-Sole et al. 2007), TANGO (Fernandez-Escamilla et al. 2004), and 
PASTA (Trovato et al. 2007) to identify amyloid-forming regions that were
 potentially capable of undergoing oligomerization. 85KMYFNLI91 and 
17AALSYGFYG25 were identified in the sequences of bv and human LfPLA2, 
respectively, by the above algorithms as regions potentially forming amyloid-type 
aggregates.  
 
 
 
4.2. Influence of oxidized phospholipids in gelsolin fibrillation 
(II) 
 
4.2.1. Kinetics of gelsolin fibrillation by ThT fluorescence assay 
 
 
The kinetics of fibril formation by the 16-residue peptide FtG179–194 in the presence 
of phospholipid membranes were monitored by ThT fluorescence assays. The 
segment comprising residues 179–194 of gelsolin contains the mutation D187N, 
which was identified previously as the amyloidogenic core of gelsolin in FAF 
(Maury et al. 1994). ThT binds to amyloid protofibrils and fibrils, resulting in a 
significant red shift in the maximum emission wavelength, together with an 
increased quantum yield (Naiki et al. 1989). We studied the fibrillation kinetics of 
wtG179–194 and FtG179–194 in the presence of varying concentrations of different lipid 
membranes POPG (X = 0.2), PazePC (X = 0.2), PoxnoPC (X = 0.2), sphingosine 
(X = 0.2), or cholesterol (X = 0.2) in POPC liposomes. Among the above lipid 
compositions, only POPC/PoxnoPC (XPoxnoPC = 0.2, Fig.3, Panel A) LUV and neat 
PoxnoPC (Fig.3, Panel B) were found to accelerate the fibrillation of FtG179–194. 
Interestingly, the enhancement of ThT intensities was directly proportional to the 
total lipid concentration.  
 
Figure 3: Kinetics of fibril formation by 15 μM FtG179–194 in the presence of 0 (○), 6.25 (∆), 12.5 (□), 
25 (◊), 50 (▲), 75 (■), and 100 μM (▼) PoxnoPC/POPC (XPoxnoPC = 0.2, panel A) LUV and neat 
PoxnoPC (panel B) in a total volume of 200 μL of 50 μM ThT in 20 mM Hepes, 0.1 mM EDTA, and 
150 mM NaCl (pH 7.0), measured at 27°C without agitation/stirring. Concentrations in mixed lipid 
vesicles refer to total phospholipids.  
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The ThT fluorescence kinetics for FtG179–194 over a period of up to 240 h in the 
presence of varying concentrations of PoxnoPC were nucleation-dependent 
following sigmoidal increases in emission with time. Next, various kinetic 
parameters (lag time, t1/2, and Kapp) were derived for each of these curves by fitting 
the data as described previously (Nielsen et al. 2001). The amplitude of ThT 
emission increased with the concentration of PoxnoPC, reaching a plateau at 
around 25–30 μM lipid and then decreasing at higher lipid concentrations (Fig. 4, 
panel A). At close to micellar concentrations (approximately 22.5 μM), PoxnoPC 
induced a maximal increase in ThT fluorescence as compared to either below or 
above the critical micelle concentration (CMC). Moreover, the lag time was 
proportional to the PoxnoPC concentration (Fig. 4, panel B). The t1/2, i.e., the half-
life of the reaction, increased with the concentration of PoxnoPC both below and 
above the CMC and was longer than that recorded for the peptide alone in the 
buffer (Fig. 4, panel C). The rate Kapp of FtG179–194 amyloid formation increased 
with the concentration of PoxnoPC and approached a maximum of around 25 μM 
lipid before decreasing at above 30 μM PoxnoPC (Fig. 4, panel D). Above the 
CMC (> 25–30 μM), increasing the concentration of PoxnoPC gradually decreased 
the value of Kapp for fibril formation because of surface dilution of the peptide.  
 
Figure 4: The amplitude of ThT emission (panel A), lag time (panel B), t1/2 (panel C), and Kapp 
(apparent growth rate constants, panel D) for 5 (▼), 10 (■), 15 (▲), and 20 μM (●) FtG179–194 in the 
presence of varying concentrations of PoxnoPC.  
 
 
4.2.2. Trp fluorescence spectroscopy of the gelsolin peptide  
 
 
In order to gain insight into PoxnoPC-FtG179–194 interactions, steady-state Trp 
fluorescence spectroscopy was used. Trp fluorescence emission depends on solvent 
polarity and reflects the exposure of Trp residues to water (Lakowicz 1983). We 
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observed a reduction in the quantum yield of FtG179–194 in the presence of 
POPC/PoxnoPC (X = 0.2) liposome, suggesting that W180 was in contact with the 
membrane hydrocarbon-water interface (Fig. 5, panel A). The progressive 
enhancement in Trp emission upon the addition of neat PoxnoPC indicated contact 
of the W180 residue with a hydrophobic region of PoxnoPC. In the presence of 
PoxnoPC, saturation in Trp fluorescence emission was close to a 1:1 FtG179–
194/PoxnoPC molar ratio, suggesting that the reaction was stoichiometric, with the 
formation of a 1:1 complex (Fig. 5, panel A). Furthermore, the efficiency of 
quenching of Trp emission was assessed using the water-soluble collisional 
quencher AcrA (Fig. 5, panel B). The efficient quenching of W180 by AcrA below 
the CMC of PoxnoPC revealed that the W180 residue was in contact with the 
aqueous phase. Considerably reduced quenching was observed at concentrations 
above the CMC, suggesting that W180 was accommodated in the hydrocarbon 
region of the micelle.  
 
Figure 5: Panel A: Relative fluorescence intensity of Trp in the presence of 10 (■) or 20 μM (●) 
FtG179–194 with the data points measured 1 min after each consecutive addition of PoxnoPC and 
depicted as a function of the L/P molar ratio. Also shown is the decrease in fluorescence in the 
presence of POPC/PoxnoPC (XPoxnoPC = 0.2, ▲) liposomes. Panel B: Stern-Volmer plots for the 
quenching by AcrA of W180 fluorescence in the presence of 20 μM FtG179–194 in a total volume of 1.8 
ml of 20 mM Hepes, 0.1 mM EDTA, and 150 mM NaCl at pH 7.0 (□) or in the presence of 12.5 (■), 
25 (▲), or 50 (▼) μM PoxnoPC. The temperature was maintained at 25°C. 
 
The long-term effects of PoxnoPC on Trp fluorescence of the FtG179–194 peptide 
shows a pronounced and progressive enhancement in W180 emission, suggesting 
that W180 in FtG179–194 was transferred into the hydrophobic milieu (Fig. 6, panel A 
and B). 
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Figure 6: Panel A: Relative fluorescence intensity (left Y axis, ●) and decrease in λmax (blue shift, 
right Y axis, ■) for W180. Panel B: Time dependence of the quenching of W180 fluorescence by 
AcrA in the presence of 20 μM FtG179–194 as a function of time in a total volume of 1.8 ml of 20 mM 
Hepes, 0.1 mM EDTA, and 150 mM NaCl at pH 7.0 and in the presence of 50 μM PoxnoPC. F0 and F 
represent fluorescence intensities recorded with continuous stirring in the absence and presence of 
250 μM AcrA, respectively. The temperature was maintained at 25°C.  
 
In conclusion, our data from Trp fluorescence measurements suggested the 
occurrence of several consecutive processes. First, there was an instant (within 
minutes) interaction between PoxnoPC and FtG179–194, resulting in an increase in 
the quantum yield of W180 emission. Simultaneously, the attenuated quenching of 
W180 by AcrA suggested that the peptide could enter into the membrane or reside 
on the level of the PC head group. The next phase (after about 6 h) was revealed by 
the progressive decrease in Trp emission, possibly because of a slow structural 
transition and assembly of FtG179–194 into amyloid fibrils, as suggested by electron 
microscopy (Fig. 7). 
 
Figure 7: Transmission electron micrographs of fibrils formed by 10 μM FtG179–194 in the presence of 
10 μM PoxnoPC after 66 (panel A) or 160 h (panel B). Scale bars represent 200 nm. 
 
 
4.3. Interaction of Hsp70 with the phospholipid membrane (III 
and IV) 
 
 
4.3.1. Light scattering measurements  
 
 
The assessment of Hsp70 binding to POPC, as well as CL, BMP, and POPS 
containing in PC LUV, was studied by relative changes in liposome 90° light 
scattering (RSI), as described by Nelsestuen and Lim (Nelsestuen et al. 1977). The 
small change in RSI upon Hsp70 addition to LUV indicated the weak binding of 
Hsp70 to the bilayer at pH 7.4 (Fig. 8, panel A). However, decreasing the pH to 4.5 
greatly enhanced the binding of Hsp70 to membranes containing acidic 
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phospholipids, especially BMP (Fig. 8, panel B). Our data revealed that the 
interaction of Hsp70 with the phospholipid membranes depended on both the lipid 
composition and pH. The drop in light scattering upon binding of Hsp70 to PS at 
pH 4.5 was probably due to aggregation of the protein with the LUV.  
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Figure 8: Relative changes in liposome 90° light scattering upon addition of Hsp70 (in 0.02-nmol 
aliquots) to liposomes composed of POPC (■), POPS/POPC (XPOPS = 0.2, ●), CL/POPC (XCL = 0.2, 
▲), or BMP/POPC (XBMP = 0.2, ▼). The initial total lipid concentration was 40 μM. The data are 
depicted as the ratio (F/F0) of the liposome scattering intensity in the presence of the indicated Hsp70 
(F) to that in 0.1 mM EDTA, 20 mM Hepes, or MES (F0) at pH 7.4 (panel A), or pH 4.5 (panels B). 
 
4.3.2. Trp fluorescence emission of Hsp70 
 
Subsequently, Trp fluorescence was used to observe the binding of Hsp70 to LUV 
mimicking organelle-specific phospholipid membranes. In buffer, Hsp70 had a 
fluorescence emission maximum at around 342 nm (Fig. 9, panels A and B). Upon 
the addition of POPC LUV, a large increase in the relative fluorescence intensity 
(RFI), together with a decrease (blue shift) in the wavelength of the maximal 
emission (λmax), indicated that Hsp70 Trp was accommodated in the more 
hydrophobic environment resulting from the presence of POPC LUV (Fig. 9). The 
RFI in presence of POPC equilibrated slowly, requiring up to 15–20 min. The 
curves revealed no signs of saturation, thus indicating a low affinity interaction, 
most likely arising from weak, nonspecific hydrophobic partitioning of Hsp70 to 
the POPC bilayer. 
Moreover, LUV containing the acidic phospholipids PS and CL also caused an 
increase in RFI, yet with a smaller reduction in λmax. When negatively charged 
lipids were present in the LUV, changes in fluorescence induced by the negatively 
charged liposomes were more rapid, and apparent equilibria were reached faster. 
The lower RFI in the presence of PS- and CL-containing LUV compared to POPC-
containing LUV may reflect the vicinity of the Trp residues to the surface charges 
of acidic phospholipid membranes. No significant differences in the λmax were seen 
for spectra recorded between pH 7.4 and 6.0 with the lipid compositions used (Fig. 
9, panels C and D). At pH 6.0, the affinity of Hsp70 for CL/PC LUV seemed to be 
high, and the binding saturated at an L/P of 75 (Fig. 9, panel F). 
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Figure 9: Tryptophan fluorescence spectra for wtHsp70 (o) in 20 mM Hepes, 0.1 mM EDTA, or in 
the presence of 95 μM (total lipid) LUV at pH 7.4 (panel A) or 6.0 (panel B). The effects of lipid 
binding on the decrement in the spectral center of mass (∆λ) for Hsp70 Trp fluorescence at pH 7.4 
(panel C) and 6.0 (panel D) and the relative fluorescence intensities (F/F0) at pH 7.4 (panel E) and 6.0 
(panel F) are shown. LUV were composed of POPC (●), CL/POPC (XCL = 0.2, ▲), or POPS/POPC 
(XPOPS = 0.2, ■). The initial protein concentration was 0.43 μM, and the total concentration of lipids 
was increased in 10 μM increments up to 100 μM. 
 
In order to elucidate the contributions of W90 and W580 to the above Trp 
fluorescence signals and the involvement of NBD and SBD in lipid interactions, 
Trp fluorescence emissions were recorded using the Hsp70 mutants Hsp70-W90F 
and Hsp70-W580F. Similar to wtHsp70, a significant enhancement in Trp 
fluorescence was seen for both Hsp70-W580F and Hsp70-W90F in the presence of 
PC, CL/PC (XCL = 0.2), or PS/PC (XPS = 0.2) LUV (Fig. 10). Accordingly, both 
NBD and SBD seemed to contribute to the membrane attachment of Hsp70. 
Compared to wtHsp70, the affinities of the W90F and W580F mutants for CL 
seemed to differ, saturating at approximately L/P ≈ 50 and 75, respectively (Fig.10, 
panel D). 
Additionally, considering the acidic environment of the endolysosomal 
compartment upon maturation to lysosomes, the binding of BMP with Hsp70, 
Hsp70-W90F, and Hsp70-W580F, as well as the NBD and SBD constructs Hsp70-
∆SBD and Hsp70-∆NBD, were compared at pH 4.5. The reduction in relative peak 
fluorescence intensities for the Hsp70 mutants Hsp70-W90F and Hsp70-ΔNBD, 
but not for those of Hsp70-W580F and Hsp70-ΔSBD, revealed that the NBD 
contained a high-affinity BMP binding site in Hsp70 (Fig. 11). 
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Figure 10: Relative fluorescence intensities for Hsp70 (○), Hsp70-W90F (W580, ■), and Hsp70-
W580F (W90, ▲) in the presence of POPC (panels A and B), CL/POPC (XCL = 0.2, panels C and D), 
and POPC/POPS (XPOPS = 0.2, panels E and F) LUV. The initial protein concentration was 0.43 μM, 
and the concentration of lipid was increased in 10-μM increments. The data are depicted as the ratio 
(F/F0) of the emission measured in the presence of the indicated LUV (F) to the emission intensity in 
20 mM Hepes, 0.1 mM EDTA (F0) at pH 7.4 (left panels) or pH 6.0 (right panels). 
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Figure 11: Relative fluorescence intensities for Hsp70 (○), Hsp70-W90F (0), Hsp70W580F (▼), 
Hsp70-∆NBD (SBD, ▲), and Hsp70-∆SBD (NBD, ●) in the presence of BMP/POPC (XCL = 0.2) 
LUV at pH 4.5. The initial protein concentration was 30 nM, and the concentrations of lipids were 
increased in 1-μM increments. The data are depicted as the ratio (F/F0) of the emission in the 
presence of the indicated LUV (F) to the emission intensity in 0.1 mM EDTA, 20 mM MES (F0) at 
37°C. 
 
4.3.3. Quenching of Trp by AcrA 
 
In order to verify the intercalation of Hsp70 into the hydrophobic region of the 
bilayers, as indicated by the above changes in Trp emission spectra, we assessed 
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the efficiency of quenching of Trp emission by the water-soluble collisional 
quencher AcrA (Lakowicz 1983). Consistent with the penetration of Hsp70 Trp 
residues into the POPC surface, quenching by AcrA was reduced in the presence of 
POPC LUV (Fig. 12). Surprisingly, the opposite was observed for negatively 
charged CL- and PS-containing LUV at both pH 7.4 and 6.0, and binding to lipids 
resulting in an enhancement of quenching by AcrA (Fig. 12). This indicated that 
upon binding to the acidic phospholipid membrane, a conformational change 
occurred, rendering at least one of the Trp residues in Hsp70 more accessible for 
AcrA quenching. 
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Figure 12: Quenching of Trp fluorescence of membrane-bound Hsp70 by AcrA. The concentrations 
of lipids and Hsp70 were 95 and 0.4 μM, respectively, corresponding to an L/P of approximately 234. 
The data are represented as the ratio of initial fluorescence intensity (F0) to the intensity measured in 
the presence of AcrA (F), at pH 7.4 (panel A) and 6.0 (panel B). The liposomes were composed of 
POPC (●), CL/POPC (XCL = 0.2, ▲), or POPS/POPC (XPOPS = 0.2, ■). Also shown are data for 
Hsp70 in buffer (○).  
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Figure 13: Acrylamide quenching for Hsp70 (○), Hsp70-W90F (W580, ■), and Hsp70-W580F (W90, 
▲) in the presence of POPC (panels A and B), CL/POPC (XCL = 0.2, panels C and D), or 
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POPS/POPC (XPOPS = 0.2, panels E and F) LUV. The concentrations of lipids and proteins were 95 
and 0.4 μM, respectively, corresponding to an L/P of approximately 234. The data are represented as 
the ratio of initial fluorescence intensity (F0) to the intensity measured in the presence of increasing 
concentrations of AcrA (F) at pH 7.4 (left panels) or pH 6.0 (right panels). 
 
The shielding of W90 in Hsp70-W580F from AcrA in the presence of PC LUV 
indicated that W90 in NBD contacted the POPC bilayer hydrocarbon region, while 
W580 in SBD still remained accessible to the bulk aqueous phase (Fig. 13, panel 
B). Interestingly, compared to Hsp70, attenuated quenching of Hsp70-W90F and 
Hsp70-W580F Trp residue fluorescence by AcrA was observed in the presence of 
CL (Fig. 13, panel D), suggesting that both domains were required for the opening 
of the Hsp70 structure when bound to CL. The reduced quenching of W90F and 
W580F by AcrA in the presence of PS/PC LUV revealed that the Trp residues were 
shielded from access to AcrA in the bulk aqueous phase (Fig. 13, panels E and F). 
 
4.3.4. Quenching of Trp by brominated phospholipids 
 
4.3.4.1. Quenching of Trp by brominated phosphatidylcholines (Br2PCs) 
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Figure 14: Quenching of Hsp70 Trp fluorescence by 6,7- (■), 9,10- (●), or 11,12Br2-PC (▲) 
containing (X = 0.3) LUV. The latter was composed of POPC (panels A and B), CL/POPC (XCL = 
0.2, panels C and D), or POPS/POPC (XPOPS = 0.2, panels E and F) LUV. The quenching efficiencies 
are depicted as the ratio of relative fluorescence intensities with LUV (F0) to LUV with the indicated 
Br2PCs (F), measured at pH 7.4 (left panels) or pH 6.0 (right panels). 
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The efficient quenching of Hsp70 Trp by 6,7-, 9,10-, and 11,12-Br2PC in POPC 
LUV at pH 7.4 indicated that Trp residues seemed to be found in the vicinity of 
carbon atoms 6 and 10 of the fatty acid chain (Fig. 14, panel A). At pH 6.0, there 
penetration of the Trp residues into POPC bilayers was less apparent (Fig. 14, 
panel B). Binding of Hsp70 to CL-containing liposomes with brominated PCs (Fig. 
14, panel D) at pH 6.0 revealed efficient quenching with similar dependence on 
L/P as seen for the Trp emission of Hsp70 in the presence of CL/PC LUV, with 
saturation observed at an L/P of approximately 50 (Fig. 9, panel F). Accordingly, 
at pH 6.0, the affinity of Hsp70 for CL/POPC LUV seemed to be high (Fig. 14, 
panels E and F). Judging from the lack of quenching by the brominated PCs, 
Hsp70 did not seem to insert into PS-containing membranes, suggesting that this 
acidic phospholipid occupied the lipid-binding site in Hsp70, which was needed for 
the quenching by brominated PCs, and displaced the latter from acidic 
phospholipid-binding sites. 
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Figure 15: Quenching of Hsp70 (○), Hsp70-W90F (W580, ■), and Hsp70-W580F (W90, ▲) Trp 
fluorescence by 6,7Br2-PC (X = 0.3) in POPC (panels A and B), CL/POPC (XCL = 0.2, panels C and 
D), or POPS/POPC (XPOPS = 0.2, panels E and F) LUV. The quenching efficiencies are depicted as 
the ratio of relative fluorescence intensities with liposomes (F0) to LUV with 6,7Br2PC (F), measured 
at pH 7.4 (left panels) or pH 6.0 (right panels).  
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6,7-Br2PC quenching data revealed the intercalation of both NBD and SBD Trps 
into POPC bilayers (Fig. 15, panels A and B). The most efficient quenching by 6,7-
Br2PC in CL/POPC LUV was observed for W580 in Hsp70-W90F, revealing the 
high-affinity interaction of SBD with CL/PC LUV (Fig. 15, panel D). These data 
suggested that SBD possessed a high-affinity binding site for CL. The lack of 
quenching by 6,7-Br2PC revealed that neither NBD nor SBD inserted into PS-
containing membranes (Fig. 15, panels E and F).  
 
4.3.4.2. Quenching of Trp by brominated cardiolipin (Br8CL) 
To further explore the interactions between CL and the Hsp70 domains, we used 
brominated CL (Br8CL). Quenching of wtHsp70 at pH 6.0 revealed a high-affinity 
interaction, saturating at an L/P of approximately 30 (Fig. 16, panel B). The 
efficient quenching observed for both Hsp70-W580F and Hsp70-W90F by Br8CL 
at pH 6.0, saturating at L/Ps of approximately 50 and 100, respectively, showed 
that both NBD and SBD contained CL binding sites (Fig. 16, panel B). These 
interactions with CL further resulted in direct contacts of the brominated acyl 
chains of CL with W90 and W580. However, the affinity of Hsp70 to the above 
CL/PC bilayers was significantly reduced by the W90F mutation. 
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Figure 16: Quenching of Hsp70 Trp (○) by Br8CL (X = 0.2, in CL/POPC LUV) at pH 7.4 (panel A) 
and of Hsp70 (○), Hsp70-W90F (W580, ■), and Hsp70-W580F (W90, ▲) at pH 6.0 (panel B). 
Quenching efficiencies are depicted as the ratio of relative fluorescence intensities with LUV without 
(F0) Br8CL to those with Br8CL (F). The initial concentration of the protein was 0.43 μM, and the 
concentration of lipids was increased in 10μM (total lipid) increments. 
 
4.3.4.3. Quenching of Trp by brominated bismonoacylglycerol phosphate 
(Br4BMP) 
To further explore the interaction between BMP and Hsp70, we used Br4BMP. 
Quenching of Hsp70 at pH 6.0 revealed a high-affinity binding, saturating at an 
L/P of approximately 30 (Fig. 17, panel B). The more efficient quenching for W90 
in Hsp70-W580F than for W580 in Hsp70-W90F by Br4BMP contained in 
BMP/PC LUV and at pH 6.0, both saturating at L/P of approximately 30, suggested 
that there were specific and pH-dependent binding sites for BMP in NBD (Fig. 17).  
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Figure 17: Quenching of Hsp70 Trp fluorescence by 6,7-(■), 9,10-(●), or 11,12Br2-PC (▲, X = 0.3) 
contained in BMP/POPC (XBMP = 0.2) LUV at pH 6.0 (panel A). Quenching of Hsp70 (○), Hsp70-
W90F (W580, ■), and Hsp70-W580F (W90, ▲) Trp fluorescence by Br4BMP (X = 0.2, in POPC 
LUV) at pH 6.0 (panel B). The quenching efficiencies are depicted as the ratio of relative 
fluorescence intensities with LUV without (F0) and with the brominated lipid (F), as indicated. 
 
4.3.4.4. Quenching of Trp by brominated phosphatidylserine (Br2PS) 
In keeping with binding of PS to Hsp70 an efficient quenching of Trp emission by 
Br2PS was observed (Fig. 18, panels A and B). Furthermore, the quenching of both 
Hsp70-W90F and Hsp70-W580F Trp residues by Br2PS at pH 6.0, both saturating 
at L/P of approximately 100 and 50, respectively, suggested that both NBD and 
SBD contained binding sites for PS (Fig. 18, panel B). 
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Figure 18: Quenching of Hsp70 Trp (○) by Br2PS (X = 0.2, in PS/POPC LUV) at pH 7.4 (panel A) 
and pH 6.0 for Hsp70 (○), Hsp70-W90F (W580, ■), and Hsp70-W580F (W90, ▲, panel B). 
Quenching efficiencies are depicted as the ratio of relative fluorescence intensities with LUV with PS 
(F0) to those with Br2PS (F). The initial concentration of the protein was 0.43 μM, while the 
concentration of lipids was increased in 10-μM increments. 
 
4.3.5. Penetration of Hsp70 into lipid monolayers 
In order to study the extent of the insertion of Hsp70 into membranes, the 
penetration of Hsp70 into lipid monolayers (Langmuir-films) residing on a 
gas/water interface was measured using a Langmuir balance. More specifically, the 
insertion of Hsp70 into monolayers at a range of initial lateral pressures π0 was 
observed by recording the increase in the surface pressure Δπ following the 
injection of Hsp70 into the aqueous subphase. The equilibrium lateral pressures 
estimated for biomembranes are approximately 33–35 mN/m (Demel et al. 1975). 
POPC Langmuir films gave exclusion pressures πc of 47 and 38 mN/m for Hsp70 
at pH 7.4 and 6.0, respectively, indicating that Hsp70 could efficiently insert into 
PC films (Fig. 19). However, the impact of acidic phospholipids on Hsp70 
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penetration was distinctly different from that with POPC, with low exclusion 
pressures πc measured for Hsp70 monolayers composed of CL/PC (XCL = 0.20), 
BMP/PC (XBMP = 0.20), and PS/PC (XPS = 0.20, Table 4). Low exclusion pressures 
in the presence of acidic phospholipids suggested a lack of significant intercalation 
of Hsp70 into lipid films. 
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Figure 19: Penetration of Hsp70 into lipid monolayers using 20 mM Hepes, 0.1 mM EDTA as the 
buffer at pH 7.4 (panel A) or 6.0 (panel B), illustrated as a function of the initial surface pressure π0 
and the increase in surface pressure (Δπ) following the injection of Hsp70 into the subphase (0.1 μM 
final concentration). Lipid monolayers were POPC (●), CL/POPC (XCL = 0.2, ▲), POPS/POPC 
(XPOPS = 0.2, ■), POPS/Chol/Spm (XPOPS = 0.10, XChol = XSpm = 0.45, □), and BMP/POPC (XBMP = 
0.2, ∆). 
 
Table 4 
Critical packing pressures (πc) for Hsp70 and corresponding lipid 
composition 
Lipid composition 
πc (mN/m) 
pH 7.4 pH 6.0 
POPC 47 38 
CL/PC (XCL = 0.20) 27.5 31 
BPM/PC (XBMP = 0.20)  27 
PS/PC (XPOPS = 0.20) 33 35 
POPS/Chol/Spm (XPOPS = 0.10, XChol = XSpm = 0.45) 31 34 
 
 
 
4.4. Modulation of the hydrolytic activity of PLA2 by Hsp70 (V) 
 
 
Hsp70 has been shown to attenuate the oligomerization of proteins into amyloid 
fibers, as previously observed with amyloid-forming proteins (Muchowski et al. 
2005). Accordingly, the influence of Hsp70 on the oligomerization and hydrolytic 
activity of PLA2 was studied in order to understand the functional role of Hsp70 in 
protein oligomerization at the membrane interface. A small increase in the extent 
of hydrolysis of PLA2 was observed in the presence of Hsp70 without ATP, 
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suggesting that Hsp70 promoted the activity of PLA2 (Fig. 20). Interestingly, a 
30% increase in the hydrolytic activity of bvPLA2 was observed in the presence of 
Hsp70 plus ATP, indicating that Hsp70 modulated the activity of PLA2 in an ATP-
dependent manner (Fig. 20). 
 
 
 
Figure 20: Hydrolysis of 1.2 μM C28-O-PHPM by 2 nM PLA2 with 2 μMATP-Mg2+ (Δ), or in the 
absence (○) and presence of 2 nM Hsp70 (□) and with 2 μM ATP-Mg2+ (■) in 2.0 ml of 5 mM Hepes, 
0.1 mM EDTA, and 1 mM CaCl2, at pH 7.4 and 37°C, with stirring. Each point represents the average 
of three independent experiments, and the error bars indicate standard deviations. The symbols 
represent only one data point out of 300, and the continuous lines connect each data point. 
 
Next, we studied the effects of Hsp70 on lysoPC-induced inhibition of PLA2. 
LysoPC is known to induce amyloid oligomerization of PLA2. Accordingly, we 
accelerated amyloid oligomerization of PLA2 by pre-incubation with lysoPC (Fig. 
21). The pre-incubation of PLA2 with lysoPC attenuated the extent of hydrolysis 
(Fig. 21). However, when Hsp70 was present together with ATP, the amount of 
product was significantly increased compared to those for PLA2 alone and for 
PLA2 pre-incubated with lysoPC (Fig. 21). 
 
 
 
Figure 21: Hydrolytic activity as a function of time for 1.25 μM C28-O-PHPM with 2 nM PLA2 (○), 
for 2 nM PLA2 pre-incubated with 20 μM lysoPC prior to adding to the substrate (●), and for 2 nM 
PLA2 pre-incubated with 20 μM lysoPC prior to adding the substrate, in which 2 nM Hsp70 and 2 
μM ATP-Mg2+ (■) were added.  
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4.5. Effects of oligomerization-mediating sequences of PLA2 on 
its hydrolytic activity (VI) 
 
 
The oligomerization-mediating sequences KMYFNLI and AALSYGFYG in bv 
and human LfPLA2, respectively, can mediate PLA2-PLA2 interactions and likely 
influence the activity of PLA2. Accordingly, the hydrolytic activities of PLA2 in 
presence of its oligomerization-mediating sequences were assessed by observing 
the hydrolysis of the pyrene-labeled phospholipid C28-O-PHPM analog.  
 
 
 
Figure 22: Inhibition of bvPLA2 by 85KMYFNLI91. Hydrolysis of 1.25 μM C28-0-PHPM by 2 nM 
bvPLA2 (○) was measured as a function of time in the presence of 2 (□) or 4 nM (∆) peptide added to 
the substrate (without pre-incubation). Alternatively, 4 pmol of the peptide was pre-incubated with 4 
pmol of bvPLA2 for 5 (●), 10 (■), or 20 (▲) min prior to addition to the substrate.  
 
The oligomerization-mediating sequences of sPLA2 were found to attenuate the 
hydrolytic activity of sPLA2. More specifically, hydrolysis of the negatively 
charged phospholipid analog C28-O-PHPM by bvPLA2 in presence of 2 nM 
KMYFNLI was decreased to 77%–85% (Fig. 22). This attenuation became more 
pronounced in presence of 4 nM of KMYFNLI (Fig. 22). Furthermore, pre-
incubation of bvPLA2 with KMYFNLI prior to the assay caused complete 
inhibition of the hydrolytic activity of PLA2 (Fig. 22).  
 
In control experiments, a scrambled peptide (YNFLIMK) was used in which the 
amino acid composition was identical to that of KMYFNLI, but with a randomized 
sequence. Importantly, the scrambled peptide did not influence the hydrolytic 
activity of bvPLA2 (Fig. 23).  
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Figure 23: Hydrolysis of 1.25 μM C28-0-PHPM by 2 nM bvPLA2 (○) was measured as a function of 
time in the presence of 80 nM of YNFLIMK (□) or 17AALSYGFYG25 (∆) pre-incubated with the 
enzyme for 10 min prior to addition to the substrate solution. 
 
We then studied the influence of AALSYGFYG, an oligomerization-mediating 
sequence of LfPLA2, on the hydrolytic activity of LfPLA2 (Table 1). The activity 
of LfPLA2 decreased by 28% in presence of 40 nM AALSYGFYG. However, in 
presence 80 nM AALSYGFYG, more pronounced attenuation was observed. The 
hydrolysis of C28-O-PHPM by LfPLA2 also decreased to approximately 36% (Fig. 
24). Furthermore, to assess the cross reactivity of this inhibition in different sPLA2 
proteins, the effects of AALSYGFYG on the activity of bvPLA2 were evaluated. 
Interestingly, AASLSYGFYG did not influence bvPLA2 activity (Fig. 23). 
 
 
 
Figure 24: Hydrolysis of 1.25 μM C28-0-PHPM by 1 μL (○) LfPLA2 as a function of time in the 
presence of 40 (□) or 80 (∆) nM 17AALSYGFYG25 pre-incubated with the enzyme for 5 min prior to 
addition to the substrate solution. Reactions were monitored in 2.0 ml of 5 mM Hepes, 0.1 mM 
EDTA, and 1 mM CaCl2 at pH 7.4 and 37°C. 
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5. DISCUSSION 
 
5.1. Amyloid-prone sequences are an inherent features of 
amphipathic α-helical AMPs (I) 
 
 
AMPs sequences can adopt different conformations depending on their 
environments (Rozek et al. 2000, Jenssen et al. 2006). Lipid membranes also play 
an important role in modulating the conformations of AMPs (Latal et al. 1997, 
Wang et al. 1998). Changes in the secondary structure of AMPs enable them to 
interact with and destabilize lipid bilayers of their target cells, exposing the 
hydrophobic regions needed for membrane incorporation and subsequent 
aggregation (Giangaspero et al. 2001). AMPs are unstructured in an aqueous 
solution, but have well-defined secondary structures upon interaction with acidic 
phospholipid bilayers (Hirsh et al. 1996). In the absence of lipid, no peptide 
oligomerization was observed, suggesting that the hydrophobic regions were not 
exposed in solution. The membrane environment thus promotes conformational 
switching to expose hydrophobic residues, which then drive self-association by 
hydrophobic interactions between the non-polar side chains. Hydrophobicity, the 
propensity to form α-helical or β-sheet secondary structures, and the net charge of 
the polypeptide chain modulate aggregation of proteins in a partially or completely 
unfolded state (Calamai et al. 2003). Here, we showed that the information about 
the secondary structure of α-helical AMPs in lipid bilayers, which was critical for 
their activity, was coded in their sequences.  
Amyloidogenic proteins/peptides contain hydrophobic sequences that, once 
exposed, are highly prone to oligomerization (Lopez de la Paz et al. 2004). Recent 
results have demonstrated that AMPs, such as tem L, tem B, LL-37, magainin 2, 
and plantaricin A, form amyloid-like Congo red-staining fibers in membranes 
containing negatively charged phospholipids (Zhao et al. 2005, Zhao et al. 2006, 
Sood et al. 2007). Sequence analysis indicated that amyloid-prone sequence were 
common features of α-helical AMPs, thus supporting the notion that the cytotoxic 
actions of α-helical AMPs and amyloid-forming peptides/proteins were the same 
and that these peptides possessed specific sequence motifs encoding the amyloid 
core structure. In conclusion, conformational switching, aggregation, and amyloid 
formation are inherent to the sequences of α-helical AMPs. The structural 
transformation of fibril-forming proteins is a prerequisite to form amyloid 
aggregates (Dobson 2003). The recognition of ambivalent sequences that can be 
easily converted between α-helical and β-sheet structures and amyloid fibrils in a 
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proper membrane environment further reveals an important new aspect of the 
molecular mechanisms of amphipathic α-helical AMPs. 
 
5.2. Mechanism of gelsolin fibrillation in the presence of 
oxidized phospholipids (II) 
 
 
FAF is a neurodegenerative disease that involves the deposition of D187N/Y 
mutant gelsolin fragments as amyloid in various tissues, accompanied by 
dermatologic, neurologic, and ophthalmologic disorders (Maury et al. 1990, Maury 
et al. 2003). The formation and cytotoxic activity of amyloid proteins are 
membrane-associated processes (Gorbenko et al. 2006a, Kinnunen 2009) wherein 
lipid-protein interactions accelerate fibrillation and induce membrane 
permeabilization (Zhao et al. 2004). Similar to other amyloid diseases, FAF is 
associated with oxidative stress. The latter results in an extensive chemical 
modification of biomolecules, such as the formation of a myriad of phospholipids 
with oxidatively modified acyl chains containing various functional groups. Here, 
we demonstrated that PoxnoPC accelerated the fibrillation of FtG179–194. PoxnoPC, 
formed upon oxidative scission of PCs bearing a cis-9 double bond containing a 
fatty acid (e.g., palmitoleic, linoleic, or linolenic acid) in the sn-2 position 
(Fruhwirth et al. 2007), is predominantly found in the extracellular compartment 
(Palinski et al. 1989). Therefore, the interactions of the extracellular D187N mutant 
gelsolin with oxidized phospholipids may be involved in the development of FAF. 
Moreover, human skin experiences the most UV light exposure, and this can also 
result in lipid oxidation (Fruhwirth et al. 2007). Therefore, this may explain the 
deposition of aggregated gelsolin in the cutaneous tissue in FAF patients 
(Tanskanen et al. 2006). 
The kinetic parameters revealed in this study indicated that the acceleration of 
fibrillation was directly dependent on both the concentration and the physical 
(aggregation) state of PoxnoPC. The maximum increases in ThT fluorescence and 
Kapp for fibril formation were observed at close to the CMC (approximately 22.5 
μM) of PoxnoPC. The rates of fibril elongation and nucleation were proportional to 
the concentration of PoxnoPC, while the rates of nucleation were different below 
and above the CMC. Our observation was consistent with enhanced amyloid fibril 
formation in the presence of lipids and surfactants at submicellar concentrations by 
apolipoprotein C-II (Hatters et al. 2001), Aβ (Sabate et al. 2005) and α- and β-syn 
(Rivers et al. 2008). Oxidative modifications of phospholipids profoundly alter the 
biophysical properties of membranes, including their polarity profiles, and are 
therefore expected to have pronounced effects on membrane-associated amyloid 
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formation (Kinnunen et al. 2012). More specifically, oxidatively modified chains 
no longer remain in the membrane hydrocarbon region, but can adopt the so-called 
extended conformation protruding into the aqueous phase (Sabatini et al. 2006, 
Mattila et al. 2008).  
Fibril formation by FtG179–194 in the presence of PoxnoPC followed simple 
nucleation-dependent kinetics with the formation of a metastable intermediate in 
the lag phase (Fig. 25). The appearance of a concentration-dependent lag phase 
indicated that PoxnoPC may stabilize transient protofibrils/prefibrillar oligomers in 
the folding/aggregation free energy landscape preceding the formation of nontoxic 
mature amyloids by FtG179–194 (Kinnunen 2009). More specifically, Trp 
fluorescence data suggested that a 1:1 complex formation by PoxnoPC and FtG179–
194 (most likely via a Schiff base) occurred at the membrane hydrocarbon-water 
interface in close proximity to the PC head group. The nucleation from transient 
lipid-peptide intermediates was slow and rate-limiting to the overall fibril 
formation process. The slow structural transition of FtG179–194 in peptide-lipid 
comicelle prefibrillar oligomers led to the formation of protofibrils. Finally, fibril 
elongation would proceed via the addition of monomers to the existing protofibrils. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: A schematic model for fibril formation by FtG179–194 in the presence of a PoxnoPC 
micelle, obeying a concentration-dependent nucleation mechanism. 
 
5.3. Hsp70 binds peripherally to acidic phospholipid membrane 
surfaces (III) 
 
 
We demonstrated that Hsp70 bound to the organelle-specific lipids CL, BMP, and 
PS found in mitochondria, lysosomes, and the membrane surface of cancer cells, 
respectively. Additionally, Hsp70 associated with the above acidic phospholipid-
containing membranes surfaces peripherally, without insertion into the lipid 
bilayers. An electrostatic attraction, hydrogen bonding, and partial penetration have 
been purposed to be the underlying mechanisms for peripheral membrane 
attachment of proteins. Here, we demonstrated a new mechanism of Hsp70 binding 
Elongation Mature amyloid fibre Oxidized phospholipid 
Gelsolin 
+
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to membrane surfaces involving hydrophobic interactions without the penetration 
into lipid bilayers. 
Our results of Trp fluorescence emission and quenching by AcrA along with 
Langmuir-balance data indicated that Hsp70 did not penetrate into bilayers in the 
presence of CL/PC LUV. Hsp70 bound peripherally to the CL/PC bilayer surface. 
However, the above result contradicted Trp quenching by brominated PCs and CL 
in keeping with the insertion of Hsp70 into the bilayer. The above contradiction, 
where the brominated acyl chain was in contact with the Trp residue of Hsp70 
without intercalation, allowed us to propose a mechanism in which brominated 
phospholipid acyl chains of PC and CL adopted the extended conformation, as 
previously described for cytochrome c (Kinnunen 1992, Kinnunen 1996). 
Similarly, Hsp70 also bound to BMP and PS peripherally via an extended 
phospholipid anchorage. 
 
5.4. The Hsp70-BMP interaction is essential for lysosomal 
membrane stabilization (IV) 
 
 
The association and localization of Hsp70 to the lysosomal membrane leads to a 
cytoprotective effect and interferes with lysosomal cell death pathways (Jäättelä 
1999, Nylandsted et al. 2000, Nylandsted et al. 2004). Here, we showed that Hsp70 
selectively bound to membranes containing BMP in an acidic environment, which 
suggested the specificity of Hsp70 towards lysosomal membranes in stress 
conditions. The Hsp70-BMP interaction plays a crucial role in the activation of the 
acid sphingomyelinase (aSMase) and stabilization of lysosomes. The enzymatic 
conversion of SM to ceramide enhances membrane acyl chain order and increases 
the lateral packing of lipid bilayers in vitro (Holopainen et al. 1998). The direct 
interaction between Hsp70 and BMP was required for this activation, and the 
downstream cytoprotective properties of Hsp70 could be blocked by an antibody 
against a BMP. Moreover, W90 of NBD was required for this interaction, and its 
mutation resulted in an Hsp70 protein with compromised BMP-binding ability, 
rendering it inactive and unable to prevent lysosomal membrane permeabilization.  
 
5.5. Hsp70 controls PLA2 oligomerization (V) 
 
 
In an ATP-dependent process, Hsp70 binds to unfolded and misfolded substrates 
and guides them to their native conformations (Lindquist et al. 1988). Here, we 
showed that Hsp70 could rescue the activity of PLA2 and reverted lysoPC-induced 
inactivation of PLA2 in an ATP-dependent manner. Most likely Hsp70 attenuating 
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the conversion of active prefibrillar oligomers of PLA2 into inactive amyloid fibers 
(Fig. 26) which resulted in more extensive hydrolysis of pyrene-labeled 
phospholipid C28-O-PHPM analog. Our results are in line with earlier observations 
that the chaperone action of Hsp70 was mediated by its binding to prefibrillar 
species of Aβ (Evans et al. 2006), α-syn (Dedmon et al. 2005), and polyglutamine 
(Wacker et al. 2004) rather than to mature fibrils. Moreover, Hsp70 has also been 
shown to increase the activity protein kinase C (PKC), serving as a stabilizing 
factor for PKC (Bazzi et al. 1992, Gao et al. 2002). Our results on the activation of 
aSMase and PLA2 suggested that Hsp70 promoted the catalytic activity of lipolytic 
enzyme by prolonging the lifetime of the active state of enzymes (Fig. 26). 
The binding of ATP to NBD induces a conformational change in SBD, which 
allows substrate recognition. The ATP-dependent activation of PLA2 by Hsp70 
indicated the association of SBD with PLA2. The structural features for substrate 
interaction/recognition involve a stretch of seven hydrophobic residues, with 
charged residues vicinal to both ends, found within every 36 amino acid stretch in 
the proteome (Rudiger et al. 1997b). Hsp70 recognizes hydrophobic residues in the 
substrates, i.e., structural features typically exposed by non-native proteins, but 
normally buried in native protein. However, it is still unclear which sequence of 
PLA2 interacts with the Hsp70. 
 
 
 
 
 
 
 
 
 
Figure 26: A schematic model for the activation of PLA2 by Hsp70 in the presence of ATP-Mg2+ 
by attenuation of the conversion of catalytically active protofibrils into inactive amyloid fibers. 
 
5.6. A peptide derived from putative oligomerization-mediating 
sequences inhibits PLA2 (VI) 
 
 
PLA2 has been implicated in inflammation and is thus connected to diverse 
diseases, such as cancer, ischemia, atherosclerosis, and schizophrenia (Dennis et al. 
2011). Therefore, the activity of PLA2 needs to be critically controlled. Along 
these lines, the catalytic rate of PLA2 can be modulated by amyloidogenic 
peptides, e.g., amyloid Aβ-peptide (Lehtonen et al. 1996), several AMPs, e.g., tem 
B, tem L, indolicidin, magainin 2 (Zhao et al. 2003), LL-37 (Pochet et al. 2006), 
Activity 
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amyloid-like fibrils Oligomers `protofibrils´ 
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bombolitin III (Signor et al. 1994), and melittin (Koumanov et al. 2003), which all 
enhance the activity of PLA2.  
The interfacial activation and oligomerization of PLA2 are interconnected 
processes. Along these lines, we showed that peptides derived from putative 
oligomerization-mediating sequences could inhibit PLA2. Moreover, tem B has 
been proposed to influence the conformational equilibrium of PLA2 by forming 
higher-order co-oligomers (Code et al. 2009), thus activating PLA2 (Zhao et al. 
2003). The amyloidogenic sequence in bvPLA2 is found within to the interfacial 
recognition site, which binds to the substrate (Scott et al. 1990) and is implicated in 
the neurotoxicity of bvPLA2 (Kini et al. 1986, Nicolas et al. 1997). Based on the 
findings mentioned above, we can conclude that a shift in oligomerization can be 
induced by peptides binding to the enzyme via both nonspecific and specific 
interactions. Identification of oligomerization-mediating sequences in different 
lipid-activated enzymes could be used to obtain specific and potent peptide 
inhibitors.
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